Publications

BibTex format

@article{Eleftheriou:2023:10.1186/s13063-022-07051-9,
author = {Eleftheriou, D and Moraes, YC and Purvis, C and Pursell, M and Morillas, MM and Kahn, R and Mossberg, M and Kucera, F and Tulloh, R and Standing, JF and Swallow, V and McCormack, R and Herberg, J and Levin, M and Wan, M and Klein, N and Connon, R and Walker, AS and Brogan, P},
doi = {10.1186/s13063-022-07051-9},
journal = {TRIALS},
title = {Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol},
url = {http://dx.doi.org/10.1186/s13063-022-07051-9},
volume = {24},
year = {2023}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Eleftheriou,D
AU  - Moraes,YC
AU  - Purvis,C
AU  - Pursell,M
AU  - Morillas,MM
AU  - Kahn,R
AU  - Mossberg,M
AU  - Kucera,F
AU  - Tulloh,R
AU  - Standing,JF
AU  - Swallow,V
AU  - McCormack,R
AU  - Herberg,J
AU  - Levin,M
AU  - Wan,M
AU  - Klein,N
AU  - Connon,R
AU  - Walker,AS
AU  - Brogan,P
DO  - 10.1186/s13063-022-07051-9
PY  - 2023///
TI  - Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol
T2  - TRIALS
UR  - http://dx.doi.org/10.1186/s13063-022-07051-9
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000923134400004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 24
ER  -

Download

DrJethroHerberg

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)